Physician profile
Gene Tekmyster
NPI 1316258304
$31,779.88
in general payments reported to CMS, 2019-2025
15 companies · $1,280 in 2025
The $1,280 reported for 2025 was more than what 92% of Sports Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,131 · 2021: $528 · 2022: $670 · 2023: $2,295 · 2024: $19K · 2025: $1,280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $4,031 · Consulting Fee: $2,200 · Travel and Lodging: $1,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,125.00 |
| Food and Beverage | $4,030.66 |
| Consulting Fee | $2,200.00 |
| Travel and Lodging | $1,094.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20,067.44 | 2021-2025 | Superion Indirect Decompression System, Wavewriter Alpha Prime 16, Intracept |
| Vertiflex, INC. | $7,962.34 | 2019 | |
| Relievant Medsystems, INC. | $1,314.70 | 2022-2023 | Intracept |
| Abbott Laboratories | $737.08 | 2021-2024 | Proclaim, Eterna |
| Stryker Corporation | $615.80 | 2025 | Mild Device Kit, Optablate |
| Saluda Medical Americas, INC. | $185.46 | 2025 | Evoke |
| Mml US, INC. | $171.20 | 2023 | Reactiv8 |
| Biotronik Nro, INC. | $147.75 | 2024 | Prospera |
| Pacira Therapeutics, INC. | $147.70 | 2019 | |
| Nevro Corp. | $136.08 | 2023-2024 | Senza |
| Nuvasive, INC. | $99.42 | 2021 | |
| Curonix LLC | $81.84 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $55.24 | 2025 | Senza |
| Medtronic, INC. | $36.84 | 2023 | Intellis Adaptivestim |
| Depuy Synthes Sales INC. | $20.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gene Tekmyster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.